ZEPOSIA .92 mg/1
ozanimod hydrochloride · CAPSULE · Celgene Corporation
No Recall History
Plain English
ZEPOSIA is a capsule containing ozanimod hydrochloride at .92 mg/1, taken oral. Manufactured by Celgene Corporation.
Key Facts
- Brand Name
- ZEPOSIA
- Generic Name
- ozanimod hydrochloride
- NDC Code (Product)
59572-820- Manufacturer
- Celgene Corporation
- Strength
- .92 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA209899
- Marketing Start
- 03/27/2020
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
fatigue731 reports
multiple sclerosis relapse577 reports
drug ineffective542 reports
headache504 reports
product dose omission issue356 reports
dizziness338 reports
nausea281 reports
diarrhoea261 reports
colitis ulcerative252 reports
pain250 reports
Frequently Asked Questions
What is ZEPOSIA used for?
ZEPOSIA contains ozanimod hydrochloride. It is a capsule taken oral. Consult your doctor for specific uses.
Is ZEPOSIA a controlled substance?
ZEPOSIA is not classified as a controlled substance by the DEA.
What is the generic name for ZEPOSIA?
The generic name for ZEPOSIA is ozanimod hydrochloride. There are 2 other brand versions of ozanimod hydrochloride.
What is the NDC code for ZEPOSIA .92 mg/1?
The NDC (National Drug Code) for ZEPOSIA .92 mg/1 is 59572-820, listed by Celgene Corporation.